The post Eli Lilly secures weight loss drug approval in China: How do rivals stack up? appeared first on Invezz ...

China’s National Medical Products Administration approved Lilly’s shot for long-term weight management on Friday ... regulator initially cleared the drug for diabetes. The shares gained ...

Novo Nordisk announced in June that its weight-loss drug Wegovy received similar approval in China. Eli Lilly and Co. (LLY) announced on its WeChat account Friday that it has won approval from ...

also approved in China, and weight-loss drug Zepbound. Eli Lilly and Novo Nordisk are racing to increase production in a weight-loss market estimated to reach at least $100 billion globally by the ...

On Friday, China’s National Medical Products Administration (NMPA) approved Eli Lilly And Co (NYSE ... Mounjaro for diabetes and Zepbound for weight loss. Related: Chinese Generic Ozempic ...

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.

The move intensifies the competition with Eli Lilly, which secured approval for its weight-loss drug in China in July but has yet to launch it. Both companies are ramping up production to ...